Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)

NCT00167583 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Behcet's Disease
Panuveitis
Posterior Uveitis
Retinal Vasculitis

Interventions

DRUG: Cyclosporin A
DRUG: Interferon-alpha2a

Sponsor

University Hospital Tuebingen